Akcea Theraps Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AKCEA THERAPS, and what generic alternatives to AKCEA THERAPS drugs are available?
AKCEA THERAPS has one approved drug.
There are four US patents protecting AKCEA THERAPS drugs.
There are twenty-eight patent family members on AKCEA THERAPS drugs in twenty-four countries and eighteen supplementary protection certificates in sixteen countries.
Drugs and US Patents for Akcea Theraps
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Akcea Theraps | TEGSEDI | inotersen sodium | SOLUTION;SUBCUTANEOUS | 211172-001 | Oct 5, 2018 | RX | Yes | Yes | 9,399,774 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Akcea Theraps | TEGSEDI | inotersen sodium | SOLUTION;SUBCUTANEOUS | 211172-001 | Oct 5, 2018 | RX | Yes | Yes | 8,697,860 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Akcea Theraps | TEGSEDI | inotersen sodium | SOLUTION;SUBCUTANEOUS | 211172-001 | Oct 5, 2018 | RX | Yes | Yes | 9,061,044 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Akcea Theraps | TEGSEDI | inotersen sodium | SOLUTION;SUBCUTANEOUS | 211172-001 | Oct 5, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Akcea Theraps | TEGSEDI | inotersen sodium | SOLUTION;SUBCUTANEOUS | 211172-001 | Oct 5, 2018 | RX | Yes | Yes | 8,101,743 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Akcea Theraps
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Akcea Theraps | TEGSEDI | inotersen sodium | SOLUTION;SUBCUTANEOUS | 211172-001 | Oct 5, 2018 | 7,015,315 | ⤷ Try a Trial |
Akcea Theraps | TEGSEDI | inotersen sodium | SOLUTION;SUBCUTANEOUS | 211172-001 | Oct 5, 2018 | 7,101,993 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Akcea Theraps Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Croatia | P20170737 | ⤷ Try a Trial |
Norway | 2019001 | ⤷ Try a Trial |
Japan | 5896175 | ⤷ Try a Trial |
Slovenia | 2563920 | ⤷ Try a Trial |
Denmark | 2563920 | ⤷ Try a Trial |
Lithuania | C2563920 | ⤷ Try a Trial |
Brazil | 112012027547 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Akcea Theraps Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2563920 | PA2019001,C2563920 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: INOTERSENAS IR JO DRUSKOS; REGISTRATION NO/DATE: EU/1/18/1296 20180706 |
2563920 | 354 1-2019 | Slovakia | ⤷ Try a Trial | PRODUCT NAME: INOTERSEN VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/18/1296 20180710 |
2563920 | C201930001 | Spain | ⤷ Try a Trial | PRODUCT NAME: INOTERSEN Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, EN PARTICULAR LA SAL SODICA; NATIONAL AUTHORISATION NUMBER: EU/1/18/1296; DATE OF AUTHORISATION: 20180706; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/18/1296; DATE OF FIRST AUTHORISATION IN EEA: 20180706 |
2563920 | 300963 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: INOTERSEN OF EEN ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/18/1296 20180710 |
2563920 | C20190002 00303 | Estonia | ⤷ Try a Trial | PRODUCT NAME: INOTERSEEN;REG NO/DATE: EU/1/18/1296 10.07.2018 |
2563920 | 132019000000004 | Italy | ⤷ Try a Trial | PRODUCT NAME: INOTERSEN(TEGSEDI); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/18/1296, 20180710 |
2563920 | LUC00096 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: INOTERSEN AND SALTS THEREOF; AUTHORISATION NUMBER AND DATE: EU/1/18/1296 20180710 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.